A Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB00947 | Fulvestrant | 2 | Active Not Recruiting | 1 |
| DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |